400-920-2911 sales@csnpharm.cn
CAS No.: 405060-95-9
Synonyms: Salubrinal
Salubrinal is a selective inhibitor of eukaryotic translation initiation factor 2 subunit α (eIF2α) dephosphorylation.
生物活性
实验方案
技术信息
CAS号 | 405060-95-9 | 储存条件 |
|
|||||
分子式 | C21H17Cl3N4OS | 运输 | 蓝冰 | |||||
分子量 | 479.81 | 别名 | Salubrinal | |||||
溶解度 |
|
动物实验配方 |
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
human 697 cell | - | Growth inhibition assay | - | Inhibition of human 697 cell growth in a cell viability assay, IC50=3.98788 μM | SANGER |
human 8-MG-BA cell | - | Growth inhibition assay | - | Inhibition of human 8-MG-BA cell growth in a cell viability assay, IC50=10.9999 μM | SANGER |
human A101D cell | - | Growth inhibition assay | - | Inhibition of human A101D cell growth in a cell viability assay, IC50=13.8207 μM | SANGER |
human A3-KAW cell | - | Growth inhibition assay | - | Inhibition of human A3-KAW cell growth in a cell viability assay, IC50=8.43289 μM | SANGER |
human ALL-PO cell | - | Growth inhibition assay | - | Inhibition of human ALL-PO cell growth in a cell viability assay, IC50=4.08655 μM | SANGER |
human ATN-1 cell | - | Growth inhibition assay | - | Inhibition of human ATN-1 cell growth in a cell viability assay, IC50=12.0226 μM | SANGER |
human BC-1 cell | - | Growth inhibition assay | - | Inhibition of human BC-1 cell growth in a cell viability assay, IC50=15.198 μM | SANGER |
human BC-3 cell | - | Growth inhibition assay | - | Inhibition of human BC-3 cell growth in a cell viability assay, IC50=14.7982 μM | SANGER |
human BE-13 cell | - | Growth inhibition assay | - | Inhibition of human BE-13 cell growth in a cell viability assay, IC50=8.2684 μM | SANGER |
human Becker cell | - | Growth inhibition assay | - | Inhibition of human Becker cell growth in a cell viability assay, IC50=5.79401 μM | SANGER |
human BL-41 cell | - | Growth inhibition assay | - | Inhibition of human BL-41 cell growth in a cell viability assay, IC50=9.78049 μM | SANGER |
human BV-173 cell | - | Growth inhibition assay | - | Inhibition of human BV-173 cell growth in a cell viability assay, IC50=11.5021 μM | SANGER |
human CESS cell | - | Growth inhibition assay | - | Inhibition of human CESS cell growth in a cell viability assay, IC50=11.6662 μM | SANGER |
human CMK cell | - | Growth inhibition assay | - | Inhibition of human CMK cell growth in a cell viability assay, IC50=13.7436 μM | SANGER |
human D-336MG cell | - | Growth inhibition assay | - | Inhibition of human D-336MG cell growth in a cell viability assay, IC50=15.1134 μM | SANGER |
human D-542MG cell | - | Growth inhibition assay | - | Inhibition of human D-542MG cell growth in a cell viability assay, IC50=13.4306 μM | SANGER |
human Daudi cell | - | Growth inhibition assay | - | Inhibition of human Daudi cell growth in a cell viability assay, IC50=6.33699 μM | SANGER |
human DOHH-2 cell | - | Growth inhibition assay | - | Inhibition of human DOHH-2 cell growth in a cell viability assay, IC50=10.2262 μM | SANGER |
human EB-3 cell | - | Growth inhibition assay | - | Inhibition of human EB-3 cell growth in a cell viability assay, IC50=9.62572 μM | SANGER |
human ES8 cell | - | Growth inhibition assay | - | Inhibition of human ES8 cell growth in a cell viability assay, IC50=8.64339 μM | SANGER |
human EVSA-T cell | - | Growth inhibition assay | - | Inhibition of human EVSA-T cell growth in a cell viability assay, IC50=12.9204 μM | SANGER |
human EW-1 cell | - | Growth inhibition assay | - | Inhibition of human EW-1 cell growth in a cell viability assay, IC50=9.7124 μM | SANGER |
human HAL-01 cell | - | Growth inhibition assay | - | Inhibition of human HAL-01 cell growth in a cell viability assay, IC50=9.31505 μM | SANGER |
human HC-1 cell | - | Growth inhibition assay | - | Inhibition of human HC-1 cell growth in a cell viability assay, IC50=11.1547 μM | SANGER |
human HCC1599 cell | - | Growth inhibition assay | - | Inhibition of human HCC1599 cell growth in a cell viability assay, IC50=12.1094 μM | SANGER |
human HEL cell | - | Growth inhibition assay | - | Inhibition of human HEL cell growth in a cell viability assay, IC50=10.6252 μM | SANGER |
human HL-60 cell | - | Growth inhibition assay | - | Inhibition of human HL-60 cell growth in a cell viability assay, IC50=13.3308 μM | SANGER |
human HT cell | - | Growth inhibition assay | - | Inhibition of human HT cell growth in a cell viability assay, IC50=8.94185 μM | SANGER |
human HUTU-80 cell | - | Growth inhibition assay | - | Inhibition of human HUTU-80 cell growth in a cell viability assay, IC50=11.6704 μM | SANGER |
human IMR-5 cell | - | Growth inhibition assay | - | Inhibition of human IMR-5 cell growth in a cell viability assay, IC50=13.7849 μM | SANGER |
human IST-SL2 cell | - | Growth inhibition assay | - | Inhibition of human IST-SL2 cell growth in a cell viability assay, IC50=11.7704 μM | SANGER |
human K-562 cell | - | Growth inhibition assay | - | Inhibition of human K-562 cell growth in a cell viability assay, IC50=11.0191 μM | SANGER |
human KE-37 cell | - | Growth inhibition assay | - | Inhibition of human KE-37 cell growth in a cell viability assay, IC50=15.2824 μM | SANGER |
human KMOE-2 cell | - | Growth inhibition assay | - | Inhibition of human KMOE-2 cell growth in a cell viability assay, IC50=13.1092 μM | SANGER |
human L-363 cell | - | Growth inhibition assay | - | Inhibition of human L-363 cell growth in a cell viability assay, IC50=13.5583 μM | SANGER |
human LB2241-RCC cell | - | Growth inhibition assay | - | Inhibition of human LB2241-RCC cell growth in a cell viability assay, IC50=4.98572 μM | SANGER |
human LB2518-MEL cell | - | Growth inhibition assay | - | Inhibition of human LB2518-MEL cell growth in a cell viability assay, IC50=7.97326 μM | SANGER |
human LP-1 cell | - | Growth inhibition assay | - | Inhibition of human LP-1 cell growth in a cell viability assay, IC50=3.37112 μM | SANGER |
human LU-139 cell | - | Growth inhibition assay | - | Inhibition of human LU-139 cell growth in a cell viability assay, IC50=14.0444 μM | SANGER |
human LXF-289 cell | - | Growth inhibition assay | - | Inhibition of human LXF-289 cell growth in a cell viability assay, IC50=11.1547 μM | SANGER |
human MC116 cell | - | Growth inhibition assay | - | Inhibition of human MC116 cell growth in a cell viability assay, IC50=11.2073 μM | SANGER |
human MHH-PREB-1 cell | - | Growth inhibition assay | - | Inhibition of human MHH-PREB-1 cell growth in a cell viability assay, IC50=6.78817 μM | SANGER |
human ML-2 cell | - | Growth inhibition assay | - | Inhibition of human ML-2 cell growth in a cell viability assay, IC50=4.61833 μM | SANGER |
human MOLT-16 cell | - | Growth inhibition assay | - | Inhibition of human MOLT-16 cell growth in a cell viability assay, IC50=13.9665 μM | SANGER |
human MRK-nu-1 cell | - | Growth inhibition assay | - | Inhibition of human MRK-nu-1 cell growth in a cell viability assay, IC50=7.75171 μM | SANGER |
human NALM-6 cell | - | Growth inhibition assay | - | Inhibition of human NALM-6 cell growth in a cell viability assay. IC50=13.0929 μM | SANGER |
human NCCIT cell | - | Growth inhibition assay | - | Inhibition of human NCCIT cell growth in a cell viability assay, IC50=11.6039 μM | SANGER |
human NCI-H510A cell | - | Growth inhibition assay | - | Inhibition of human NCI-H510A cell growth in a cell viability assay, IC50=7.03535 μM | SANGER |
human NCI-H720 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H720 cell growth in a cell viability assay, IC50=7.57268 μM | SANGER |
human NEC8 cell | - | Growth inhibition assay | - | Inhibition of human NEC8 cell growth in a cell viability assay, IC50=6.05331 μM | SANGER |
human NKM-1 cell | - | Growth inhibition assay | - | Inhibition of human NKM-1 cell growth in a cell viability assay, IC50=10.6196 μM | SANGER |
human NTERA-S-cl-D1 cell | - | Growth inhibition assay | - | Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay, IC50=12.8888 μM | SANGER |
human OVCAR-4 cell | - | Growth inhibition assay | - | Inhibition of human OVCAR-4 cell growth in a cell viability assay, IC50=14.7604 μM | SANGER |
human ST486 cell | - | Growth inhibition assay | - | Inhibition of human ST486 cell growth in a cell viability assay, IC50=8.5368 μM | SANGER |
human TE-12 cell | - | Growth inhibition assay | - | Inhibition of human TE-12 cell growth in a cell viability assay, IC50=11.3357 μM | SANGER |
MONO-MAC-6 cell | - | Growth inhibition assay | - | Inhibition of human MONO-MAC-6 cell growth in a cell viability assay, IC50=10.5483 μM | SANGER |
PC12 cells | - | Function assay | - | Cytoprotective activity on rat tunicamycin treated rat pheochromocytoma cell line PC12 from apoptosis induced by Endoplasmic reticulum stress, EC50=15 μM | 16002288 |
Ramos-2G6-4C10 cell | - | Growth inhibition assay | - | Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay, IC50=9.90315 μM | SANGER |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网